Stockscreener 앱 받기
2.00
10.71%
-0.24
시간 외 거래:
2.03
0.03
+1.50%
전일 마감가:
$2.24
열려 있는:
$2.18
하루 거래량:
11.41M
Relative Volume:
1.45
시가총액:
$600.74M
수익:
$188.87M
순이익/손실:
$-400.38M
주가수익비율:
-1.3333
EPS:
-1.5
순현금흐름:
$-260.90M
1주 성능:
+1.52%
1개월 성능:
+34.23%
6개월 성능:
+76.99%
1년 성능:
-20.32%
1일 변동 폭
$1.985
$2.21
1주일 범위
$1.91
$2.37
52주 변동 폭
$0.8511
$2.72
퍼시픽 바이오 사이언스 Stock (PACB) Company Profile
명칭
Pacific Biosciences Of California Inc
전화
650-521-8000
주소
1305 O'BRIEN DRIVE, MENLO PARK, CA
PACB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.00 | 672.83M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
125.84 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
퍼시픽 바이오 사이언스 Stock (PACB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-22 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-04-18 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-17 | 업그레이드 | UBS | Neutral → Buy |
| 2023-10-31 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-06-30 | 개시 | Goldman | Buy |
| 2023-05-10 | 개시 | Barclays | Equal Weight |
| 2023-03-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2023-01-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 재개 | Piper Sandler | Neutral |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-09-27 | 개시 | Canaccord Genuity | Buy |
| 2021-02-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-15 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 개시 | Cowen | Outperform |
| 2017-11-03 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | 다운그레이드 | CL King | Buy → Neutral |
| 2016-11-03 | 재확인 | Cantor Fitzgerald | Buy |
| 2016-06-27 | 개시 | CL King | Buy |
| 2016-04-15 | 개시 | First Analysis Sec | Overweight |
| 2016-02-04 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 재확인 | Cantor Fitzgerald | Buy |
| 2015-10-23 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 개시 | Cantor Fitzgerald | Buy |
| 2015-02-04 | 재확인 | Maxim Group | Buy |
| 2013-09-26 | 재확인 | Maxim Group | Buy |
| 2013-01-14 | 재확인 | Maxim Group | Buy |
모두보기
퍼시픽 바이오 사이언스 주식(PACB)의 최신 뉴스
PacBio (PACB) Achieves Milestone with Approval in China for Sequ - GuruFocus
Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
PacBio's Sequel II CNDx System Receives Class III Medical Device Approval in China Through Partnership with Berry Genomics - Quiver Quantitative
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China - Yahoo Finance
Will Pacific Biosciences of California Inc. continue its uptrendMarket Risk Summary & Capital Protection Trade Alerts - newser.com
Is Pacific Biosciences of California Inc. stock ready for a breakout2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Will Pacific Biosciences of California Inc. stock recover after recent dropJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
Does Pacific Biosciences of California Inc. stock trade at a discount to peersJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
Price action breakdown for Pacific Biosciences of California Inc.July 2025 Decliners & Target Return Focused Picks - newser.com
How resilient is Pacific Biosciences of California Inc. stock in market downturnsCEO Change & Smart Money Movement Alerts - newser.com
PacBio Earnings: What To Look For From PACB - FinancialContent
Pacific Biosciences of California Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Pacific Biosciences of California showcases live Vega demos at AMP 2025 - Traders Union
How to build a custom watchlist for Pacific Biosciences of California Inc.July 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Is Pacific Biosciences of California Inc. stock a top pick in earnings seasonTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Analyzing recovery setups for Pacific Biosciences of California Inc. investors2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Will Pacific Biosciences of California Inc. stock split attract more investorsMarket Movement Recap & Reliable Breakout Forecasts - newser.com
Smart tools for monitoring Pacific Biosciences of California Inc.’s price action2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Statistical indicators supporting Pacific Biosciences of California Inc.’s strengthProduct Launch & Verified High Yield Trade Plans - newser.com
Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosWatch List & Trade Opportunity Analysis - newser.com
Can Pacific Biosciences of California Inc. stock resist market sell offsWeekly Market Report & Safe Capital Growth Tips - newser.com
Why Pacific Biosciences of California Inc. stock is favored by top institutionsJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Is Pacific Biosciences of California Inc. (P09) stock a buy before new product rolloutJobs Report & AI Driven Stock Reports - newser.com
Custom strategy builders for tracking Pacific Biosciences of California Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
What makes Pacific Biosciences of California Inc. stock attractive to growth fundsEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Will Pacific Biosciences of California Inc. stock sustain high P E ratios2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com
What analysts say about Pacific Biosciences of California Inc P09 stockAutomated Trading Signals & Small Capital Wealth Plans - earlytimes.in
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpHere's What Happened - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛
Carret Asset Management LLC Buys New Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (PACB) latest stock news and headlines - Yahoo! Finance UK
ARK’s PACB Share Buy: Could Institutional Confidence Signal a Turning Point for Pacific Biosciences? - Yahoo Finance
Pacific Biosciences of California emphasizes advanced research initiatives - Traders Union
PacBio (PACB) Shares Skyrocket, What You Need To Know - Yahoo Finance
퍼시픽 바이오 사이언스 (PACB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.23%
자본화:
|
볼륨(24시간):